Table 2.

Percentages of relative homologous and heterologous seroneutralization titers

Immunised serum	BTV serotype
	BTV1	BTV2	BTV4	BTV8	BTV9	BTV16
Control	0.52	1.11	0.55	0.44	0	3.54
BTV1	100	1.11	8.85	25	0	3.54
BTV2	1.3	100	3.15	0.44	0	3.54
BTV4	0.65	0.88	100	0.44	0	12.5
BTV8	10.36	12.5	25	100	6.25	3.54
BTV9	2.61	3.1	0.77	0.44	100	3.54
BTV16	18.34	12.39	0.83	0.44	0	100